GSA CAPITAL PARTNERS LLP - CATALYST BIOSCIENCES INC ownership

CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 43 filers reported holding CATALYST BIOSCIENCES INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of CATALYST BIOSCIENCES INC
ValueSharesWeighting
Q3 2021$722,000
-1.6%
175,751
+3.7%
0.07%
-10.8%
Q2 2021$734,000
+460.3%
169,535
+553.8%
0.08%
+277.3%
Q1 2021$131,000
+63.8%
25,932
+105.2%
0.02%
+69.2%
Q4 2020$80,000
-65.5%
12,635
-62.9%
0.01%
-51.9%
Q4 2019$232,000
-22.4%
34,047
-16.0%
0.03%
-18.2%
Q2 2019$299,000
-91.3%
40,526
-87.3%
0.03%
-82.6%
Q3 2018$3,449,000
+88.1%
319,915
+103.6%
0.19%
+108.8%
Q2 2018$1,834,000157,1450.09%
Other shareholders
CATALYST BIOSCIENCES INC shareholders Q3 2019
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 3,076,376$13,321,0006.97%
22NW, LP 1,429,242$6,189,0001.66%
Ghost Tree Capital, LLC 1,000,000$4,330,0001.19%
ACUTA CAPITAL PARTNERS, LLC 685,000$2,966,0001.18%
Sio Capital Management, LLC 623,892$2,701,0000.67%
Parkman Healthcare Partners LLC 393,449$1,704,0000.37%
Nantahala Capital Management 2,531,360$10,961,0000.31%
AlphaCentric Advisors LLC 182,500$790,0000.22%
Ikarian Capital, LLC 581,200$2,518,0000.20%
Tibra Equities Europe Ltd 79,200$343,0000.11%
View complete list of CATALYST BIOSCIENCES INC shareholders